All day and every day, some of the stock market's best and brightest traders and money managers share their ideas, insights and analysis in real-time on Minyanville's Buzz & Ban

Editor's Note: This article was written by Richard Suttmeier, chief market strategist at ValuEngine.com, which is a fundamentally-based quant research firm in Princeton, New Jersey, that

If we've learned one thing this week, it's that pre-anticipating pins rarely works well. See Reviewing Four Tech Stock Pins.Even with yesterday's mini excitement, it's still not a volatile week.

The chorus of “I’m Forever Blowing Bubbles”, music by John Kellette, and lyrics by James Kendis, James Brockman, and Nat Vincent, first performed on Broadway in 1918 (That’s r

A popular prescription in the personal finance domain is to increase or maximize annual contributions to 401(k)s or similar retirement plans. However, one of the best financial decisions I’ve m

The pharmaceutical landscape is rapidly changing as patents for some of the blockbuster drugs of the last decade near expiration and other players try to grab some of the remaining revenues before ge

Editor's Note: The following is a free edition of Jeff Cooper's Daily Market Report. For a 2-week trial FREE trial of his daily commentary and nightly day and swing trading picks, click here.Here com

Editor's Note: See Ron Coby's first "letter" to Ben Bernanke here.  And his "thank you note" to Ben here. This is for illustrative purposes only and isn't an offer to buy or

Editor's Note: This article was written by Richard Suttmeier, chief market strategist at ValuEngine.com, which is a fundamentally-based quant research firm in Princeton, New Jersey, that covers more

Vivus (VVUS) is raising the bar on erectile dysfunction drugs, potentially becoming the latest formidable competitor to Viagra and Cialis in the $3.8 billion market. Investors in the California-based